Literature DB >> 19085091

Targeted delivery with peptidomimetic conjugated self-assembled nanoparticles.

Esmaiel Jabbari1.   

Abstract

Peptides produce specific nanostructures, making them useful for targeting in biological systems but they have low bioavailability, potential immunogenicity and poor metabolic stability. Peptidomimetic self-assembled NPs can possess biological recognition motifs as well as providing desired engineering properties. Inorganic NPs, coated with self-assembled macromers for stability and anti-fouling, and conjugated with target-specific ligands, are advancing imaging from the anatomy-based level to the molecular level. Ligand conjugated NPs are attractive for cell-selective tumor drug delivery, since this process has high transport capacity as well as ligand dependent cell specificity. Peptidomimetic NPs can provide stronger interaction with surface receptors on tumor cells, resulting in higher uptake and reduced drug resistance. Self-assembled NPs conjugated with peptidomimetic antigens are ideal for sustained presentation of vaccine antigens to dendritic cells and subsequent activation of T cell mediated adaptive immune response. Self-assembled NPs are a viable alternative to encapsulation for sustained delivery of proteins in tissue engineering. Cell penetrating peptides conjugated to NPs are used as intracellular delivery vectors for gene expression and as transfection agents for plasmid delivery. In this work, synthesis, characterization, properties, immunogenicity, and medical applications of peptidomimetic NPs in imaging, tumor delivery, vaccination, tissue engineering, and intracellular delivery are reviewed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19085091     DOI: 10.1007/s11095-008-9802-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  223 in total

1.  Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: insights of the mechanism of action.

Authors:  Samuel Zalipsky; Maha Saad; Radwan Kiwan; Elizabeth Ber; Ning Yu; Tamara Minko
Journal:  J Drug Target       Date:  2007 Aug-Sep       Impact factor: 5.121

2.  Evaluation of quantum dot cytotoxicity based on intracellular uptake.

Authors:  Emmanuel Chang; Nadhi Thekkek; William W Yu; Vicki L Colvin; Rebekah Drezek
Journal:  Small       Date:  2006-12       Impact factor: 13.281

Review 3.  Peptide self-assembly at the nanoscale: a challenging target for computational and experimental biotechnology.

Authors:  Giorgio Colombo; Patricia Soto; Ehud Gazit
Journal:  Trends Biotechnol       Date:  2007-03-26       Impact factor: 19.536

Review 4.  Intracellular destinies: degradation, targeting, assembly, and endocytosis of HIV Gag.

Authors:  Kevin C Klein; Jonathan C Reed; Jaisri R Lingappa
Journal:  AIDS Rev       Date:  2007 Jul-Sep       Impact factor: 2.500

5.  Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion.

Authors:  Lisa B E Shields; George H Raque; Steven D Glassman; Mitchell Campbell; Todd Vitaz; John Harpring; Christopher B Shields
Journal:  Spine (Phila Pa 1976)       Date:  2006-03-01       Impact factor: 3.468

6.  Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages.

Authors:  A Raz; C Bucana; W E Fogler; G Poste; I J Fidler
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

7.  A human single-chain antibody specific for integrin alpha3beta1 capable of cell internalization and delivery of antitumor agents.

Authors:  Antonietta M Lillo; Chengzao Sun; Changshou Gao; Henrik Ditzel; Jay Parrish; Carla-Marie Gauss; Jason Moss; Brunhilde Felding-Habermann; Peter Wirsching; Dale L Boger; Kim D Janda
Journal:  Chem Biol       Date:  2004-07

Review 8.  The coordination of signaling during Fc receptor-mediated phagocytosis.

Authors:  Joel A Swanson; Adam D Hoppe
Journal:  J Leukoc Biol       Date:  2004-10-05       Impact factor: 4.962

Review 9.  Focusing on clathrin-mediated endocytosis.

Authors:  Joshua Z Rappoport
Journal:  Biochem J       Date:  2008-06-15       Impact factor: 3.857

10.  Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.

Authors:  Ashwin Basarkar; Dilip Devineni; Ravi Palaniappan; Jagdish Singh
Journal:  Int J Pharm       Date:  2007-05-18       Impact factor: 5.875

View more
  5 in total

Review 1.  Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Authors:  Xiao-Xiang Zhang; Henry S Eden; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-10-26       Impact factor: 9.776

2.  Amphiphilic block co-polyesters bearing pendant cyclic ketal groups as nanocarriers for controlled release of camptothecin.

Authors:  Xiaoying Wang; Lisa A Gurski; Sheng Zhong; Xian Xu; Darrin J Pochan; Mary C Farach-Carson; Xinqiao Jia
Journal:  J Biomater Sci Polym Ed       Date:  2011       Impact factor: 3.517

3.  Synthesis and in vitro inhibition properties of oligonucleotide conjugates carrying amphipathic proline-rich peptide derivatives of the sweet arrow peptide (SAP).

Authors:  Santiago Grijalvo; Ramon Eritja
Journal:  Mol Divers       Date:  2012-03-06       Impact factor: 2.943

4.  Drug release kinetics, cell uptake, and tumor toxicity of hybrid VVVVVVKK peptide-assembled polylactide nanoparticles.

Authors:  Esmaiel Jabbari; Xiaoming Yang; Seyedsina Moeinzadeh; Xuezhong He
Journal:  Eur J Pharm Biopharm       Date:  2012-12-27       Impact factor: 5.571

5.  Nanotheranostics through Mitochondria-targeted Delivery with Fluorescent Peptidomimetic Nanohybrids for Apoptosis Induction of Brain Cancer Cells.

Authors:  Isadora C Carvalho; Alexandra A P Mansur; Sandhra M Carvalho; Herman S Mansur
Journal:  Nanotheranostics       Date:  2021-02-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.